ERBB2 and breast carcinoma: Aggressive breast cancers overexpress Epidermal Growth Factor Receptor (EGFR) family members where ~ 25% of breast cancer patients overexpress human epidermal growth factor receptor 2 (HER2) and ~ 15% overexpress the EGFR1 isoform [1].